Porta-Vázquez M, López-Cedrún JL, Fernández-Sanromán J, García-Mato E, Diz-Dios P, Diniz-Freitas M, et al. Estimating the direct costs of oral cancer in Spain: a retrospective hospital data analysis. Med Oral Patol Oral Cir Bucal. 2023 Sep 1;28 (5):e425-32.
doi:10.4317/medoral.25847
https://dx.doi.org/doi:10.4317/medoral.25847
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209-49. |
PMid:33538338 |
2. O'Sullivan A, Kabir Z, Harding M. Lip, oral cavity and pharyngeal cancer burden in the European Union from 1990-2019 using the 2019 Global Burden of Disease study. Int J Environ Res Public Health. 2022;19:6532. |
PMid:35682117 PMCid:PMC9180496 |
3. Milani V, Zara ALSA, da Silva EN, Cardoso LB, Curado MP, Ribeiro-Rotta RF. Direct healthcare costs of lip, oral cavity and oropharyngeal cancer in Brazil. PLoS One. 2021;16:e0246475. |
PMid:33596233 PMCid:PMC7888595 |
4. Wissinger E, Griebsch I, Lungershausen J, Foster T, Pashos CL. The economic burden of head and neck cancer: a systematic literature review. Pharmacoeconomics. 2014;32:865-82. |
PMid:24842794 PMCid:PMC4153967 |
5. Ribeiro-Rotta RF, Rosa EA, Milani V, Dias NR, Masterson D, da Silva EN, et al. The cost of oral cancer: A systematic review. PLoS One. 2022;17:e0266346. |
PMid:35446870 PMCid:PMC9022815 |
6. Badía X, Tort M, Manganelli AG, Camps C, Díaz-Rubio E. The burden of cancer in Spain. Clin Transl Oncol. 2019;21:729-34. |
PMid:30414063 |
7. Ibarrondo O, Lizeaga G, Martínez-Llorente JM, Larrañaga I, Soto-Gordoa M, Álvarez-López I. Health care costs of breast, prostate, colorectal and lung cancer care by clinical stage and cost component. Gac Sanit. 2022;36:246-52. |
PMid:33612313 |
8. Jacobson JJ, Epstein JB, Eichmiller FC, Gibson TB, Carls GS, Vogtmann E. The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, Medicare, and Medicaid. Head Neck Oncol. 2012;4:15. |
PMid:22537712 PMCid:PMC3503554 |
9. Schernberg A, Sagaon-Teyssier L, Schwarzinger M, EPICORL Study Group. Clinical and economic burden of head and neck cancer: a nationwide retrospective cohort study from France. Clinicoecon Outcomes Res. 2019;11:441-51. |
PMid:31413607 PMCid:PMC6661373 |
10. Polesel J, Lupato V, Collarile P, Vaccher E, Fanetti G, Giacomarra V, et al. Direct health-care cost of head and neck cancers: a population-based study in north-eastern Italy. Med Oncol. 2019;36:31. |
PMid:30815763 |
11. Zavras A, Andreopoulos N, Katsikeris N, Zavras D, Cartsos V, Vamvakidis A. Oral cancer treatment costs in Greece and the effect of advanced disease. BMC Public Health. 2002;2:1-8. |
PMid:12133170 PMCid:PMC117788 |
12. Van Agthoven M, Van Ineveld BM, De Boer MF, Leemans CR, Knegt PP, Snow GB, et al. The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up. Eur J Cancer. 2001;37:2204-11. |
PMid:11677108 |
13. Kim K, Amonkar MM, Högberg D, Kasteng F. Economic burden of resected squamous cell carcinoma of the head and neck in an incident cohort of patients in the UK. Head Neck Oncol. 2011;3:47. |
PMid:22035422 PMCid:PMC3219567 |
14. Johns B, Baltussen R, Hutubessy R. Programme costs in the economic evaluation of health interventions. Cost Eff Resour Alloc. 2003;1:1. |
PMid:12773220 PMCid:PMC156020 |
15. Raman S, Shafie AA, Abraham MT, Shim CK, Maling TH, Rajendran S, et al. Provider cost of treating oral potentially malignant disorders and oral cancer in Malaysian public hospitals. PLoS One. 2021;16:e0251760. |
PMid:33984051 PMCid:PMC8118562 |
16. Han S, Chen Y, Ge X, Zhang M, Wang J, Zhao Q, et al. Epidemiology and cost analysis for patients with oral cancer in a university hospital in China. BMC Public Health. 2010;10:196. |
PMid:20398380 PMCid:PMC2864212 |
17. Funk GF, Hoffman HT, Karnell LH, Ricks JM, Zimmerman MB, Corbae DP, et al. Cost-identification analysis in oral cavity cancer management. Otolaryngol Head Neck Surg. 1998;118:211-20. |
PMid:9482555 |
18. Pai K, Baaklini C, Cabrera CI, Tamaki A, Fowler N, Maronian N. The utility of comorbidity indices in assessing head and neck surgery outcomes: a systematic review. Laryngoscope. 2022;132:1388-402. |
PMid:34661923 |
19. Hennessey PT, Francis HW, Gourin CG. Is there a "July effect" for head and neck cancer surgery?. Laryngoscope. 2013;123:1889-95. |
PMid:23737378 |
20. Kowalski LP, Oliveira MM, Lopez RVM, Silva DRME, Ikeda MK, Curado MP. Survival trends of patients with oral and oropharyngeal cancer treated at a cancer center in São Paulo, Brazil. Clinics (Sao Paulo). 2020;6:1507. |
PMid:32294669 PMCid:PMC7134554 |
21. Amarasinghe H, Jayasinghe RD, Dharmagunawardene D, Attygalla M, Scuffham PA, Johnson N, et al. Economic burden of managing oral cancer patients in Sri Lanka: a cross-sectional hospital-based costing study. BMJ Open. 2019;9:e027661. |
PMid:31326930 PMCid:PMC6661677 |
22. Pollaers K, Massingham I, Friedland PL, Farah CS. The economic burden of oral squamous cell carcinoma in Australia. J Oral Pathol Med. 2019;48:588-94. |
PMid:31177557 |
23. Rezapour A, Jahangiri R, Olyaeemanesh A, Kalaghchi B, Nouhi M, Nahvijou A. The economic burden of oral cancer in Iran. PLoS One. 2018;13:e0203059. |
PMid:30260976 PMCid:PMC6160006 |
24. Silfverschiöld M, Sjövall J, Wennerberg J, Östensson E, Greiff L. Societal cost of oropharyngeal cancer by human papillomavirus status, cancer stage, and subsite. PLoS One. 2019;14:e0220534. |
PMid:31356646 PMCid:PMC6663066 |
25. Huang SY, Chen HM, Liao KH, Ko BS, Hsiao FY. Economic burden of cancers in Taiwan: a direct and indirect cost estimate for 2007-2017. BMJ Open. 2020;10:e036341. |
PMid:33039986 PMCid:PMC7549455 |
26. Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20:327-37. |
PMid:25548737 PMCid:PMC4278062 |
27. Klussmann JP, Schädlich PK, Chen X, Rémy V. Annual cost of hospitalization, inpatient rehabilitation, and sick leave for head and neck cancers in Germany. Clin Outcomes Res. 2013;5:203-13. |
PMid:23717047 PMCid:PMC3662462 |
28. Patterson RH, Fischman VG, Wasserman I, Siu J, Shrime MG, Fagan JJ, et al. Global burden of head and neck cancer: economic consequences, health, and the role of surgery. Otolaryngol Head Neck Surg. 2020;162:296-303. |
PMid:31906785 |
29. Carazo-Casas C, Gil-Prieto R, Hernández-Barrera V, Gil de Miguel Á. Trends in hospitalization and death rates among patients with head and neck cancer in Spain, 2009 to 2019. Hum Vaccin Immunother. 2022;18:2082192. |
PMid:35930449 PMCid:PMC9621082 |
30. Mignogna MD, Fedele S, Lo Russo L, Ruoppo E, Lo Muzio L. Costs and effectiveness in the care of patients with oral and pharyngeal cancer: analysis of a paradox. Eur J Cancer Prev. 2002;11:205-8. |
PMid:12131652 |